These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
808 related articles for article (PubMed ID: 32337748)
21. Dysbiosis signatures of gut microbiota in coronary artery disease. Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713 [TBL] [Abstract][Full Text] [Related]
22. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers. Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961 [TBL] [Abstract][Full Text] [Related]
23. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer. Zhang Q; Zhao H; Wu D; Cao D; Ma W BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883 [TBL] [Abstract][Full Text] [Related]
24. Using fecal immunochemical tubes for the analysis of the gut microbiome has the potential to improve colorectal cancer screening. Krigul KL; Aasmets O; Lüll K; Org T; Org E Sci Rep; 2021 Oct; 11(1):19603. PubMed ID: 34599256 [TBL] [Abstract][Full Text] [Related]
25. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Wu N; Yang X; Zhang R; Li J; Xiao X; Hu Y; Chen Y; Yang F; Lu N; Wang Z; Luan C; Liu Y; Wang B; Xiang C; Wang Y; Zhao F; Gao GF; Wang S; Li L; Zhang H; Zhu B Microb Ecol; 2013 Aug; 66(2):462-70. PubMed ID: 23733170 [TBL] [Abstract][Full Text] [Related]
26. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865 [TBL] [Abstract][Full Text] [Related]
27. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice. Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860 [TBL] [Abstract][Full Text] [Related]
28. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641 [TBL] [Abstract][Full Text] [Related]
29. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer. Avuthu N; Guda C Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483 [TBL] [Abstract][Full Text] [Related]
30. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer. Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463 [TBL] [Abstract][Full Text] [Related]
31. Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population. Iadsee N; Chuaypen N; Techawiwattanaboon T; Jinato T; Patcharatrakul T; Malakorn S; Petchlorlian A; Praditpornsilpa K; Patarakul K Sci Rep; 2023 Apr; 13(1):6702. PubMed ID: 37095272 [TBL] [Abstract][Full Text] [Related]
32. Faecal microbial biomarkers in early diagnosis of colorectal cancer. Olovo CV; Huang X; Zheng X; Xu M J Cell Mol Med; 2021 Dec; 25(23):10783-10797. PubMed ID: 34750964 [TBL] [Abstract][Full Text] [Related]
33. Using fecal immmunochemical cartridges for gut microbiome analysis within a colorectal cancer screening program. Brezina S; Borkovec M; Baierl A; Bastian F; Futschik A; Gasche N; Gruenberger T; Hallas M; Jannsen C; Leeb G; Lutz R; Sladek B; Gsur A Gut Microbes; 2023; 15(1):2176119. PubMed ID: 36794815 [TBL] [Abstract][Full Text] [Related]
34. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer. Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781 [TBL] [Abstract][Full Text] [Related]
35. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer. Shah MS; DeSantis TZ; Weinmaier T; McMurdie PJ; Cope JL; Altrichter A; Yamal JM; Hollister EB Gut; 2018 May; 67(5):882-891. PubMed ID: 28341746 [TBL] [Abstract][Full Text] [Related]
36. Altered Gut Archaea Composition and Interaction With Bacteria Are Associated With Colorectal Cancer. Coker OO; Wu WKK; Wong SH; Sung JJY; Yu J Gastroenterology; 2020 Oct; 159(4):1459-1470.e5. PubMed ID: 32569776 [TBL] [Abstract][Full Text] [Related]
37. Correlations between Intestinal Microbiota and Clinical Characteristics in Colorectal Adenoma/Carcinoma. Lin C; Li B; Tu C; Chen X; Guo M Biomed Res Int; 2022; 2022():3140070. PubMed ID: 35937408 [TBL] [Abstract][Full Text] [Related]
38. Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer. Gao W; Gao X; Zhu L; Gao S; Sun R; Feng Z; Wu D; Liu Z; Zhu R; Jiao N Gut Microbes; 2023 Dec; 15(2):2245562. PubMed ID: 37635357 [TBL] [Abstract][Full Text] [Related]
39. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine. Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935 [TBL] [Abstract][Full Text] [Related]
40. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer. Fan X; Jin Y; Chen G; Ma X; Zhang L Digestion; 2021; 102(4):508-515. PubMed ID: 32932258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]